Abstract:Abstract Real-time quantitative PCR (RT-qPCR) is a widely used method for quantifying microRNA (miRNA) expression, but its accuracy depends on appropriate normalization. RT-qPCR is susceptible to technical variation from several sources, including sample collection and storage, miRNA quantity/quality, and extraction and amplification efficiencies. Normalization corrects for these factors, theoretically leaving behind only biological variation. With growing interest in miRNAs as biomarkers for the diagnosis and prognosis of various cancers, analyses must be accurate and consistent. Primarily, the comparative Ct method is used, which compares the expression of miRNAs to a reference value. Unfortunately, there is a lack of consistency on what to use as a reference. A standard recommendation is the average of multiple, stable miRNAs referred to as endogenous controls (ECs). Currently, there are no known universally stable miRNAs. Therefore, ECs should be selected on a per-disease and per-sample type basis. Multiple algorithms exist to identify stable ECs, but few studies indicate what, if any, steps were taken to implement them correctly. Also, many studies have used non-ideal reference values such as small nuclear RNAs or a single miRNA. This lack of agreement on protocol often leads to difficulty comparing studies and may produce incorrect results. This work addresses these inconsistencies by making recommendations for the normalization of RT-qPCR miRNA expression. We compared 2 widely used methods for EC selection, NormFinder and GeNorm, and to show how normalization influences results we also used an unstable miRNA. Only miRNAs with expression in all samples were considered as potential ECs. GeNorm is sensitive to correlated genes. Therefore, for any pair or trio of correlated miRNAs 1 was kept. NormFinder performs optimally with 5-10 candidate genes; therefore, we tested the 10 miRNAs with the lowest coefficients of variation (CV). The top 3 stable miRNAs were selected from each algorithm to serve as ECs, and we used their average expression to normalize each sample. For the single miRNA, samples were scaled based on its value. We applied these methods to 3 independent datasets: First, plasma samples from a study on canine osteosarcoma (OSA), including pre-amputation (n=45), post-amputation (n=27), and healthy controls (n=21). Second, tissue samples from a study on canine OSA, including primary tumour (n=42) and lung metastases (n=12). Third, serum samples from a study on canine lymphoma included B-cell (n=24), T-cell (n=16), and healthy controls (n=14). For datasets 1 and 3, NormFinder provided a better reduction in gene-specific CV and a more favourable cumulative distribution of the CV. For dataset 2, there was less initial variability, but NormFinder still had slightly better results. Both algorithms had pros and cons, but NormFinder consistently provides a better reduction in sample variation across datasets. Citation Format: Heather Treleaven, Latasha Ludwig, Alicia Viloria-Petit, R. Darren Wood, Ayesha Ali, Geoffrey A. Wood. Comparison of normalization methods for RT-qPCR microRNA expression in cancer datasets [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 2350.

Comparison of 12 Reference Genes for Normalization of Gene Expression Levels in Epstein-Barr Virus-Transformed Lymphoblastoid Cell Lines and Fibroblasts

Identification of Suitable Reference Genes for Measurement of Gene Expression in Human Cervical Tissues.

Selection of Suitable Reference Genes for Normalization of Quantitative Real-Time Polymerase Chain Reaction in Human Cartilage Endplate of the Lumbar Spine

Selection of superior reference genes' combination for quantitative real-time PCR in B-cell lymphomas

Normalization with genes encoding ribosomal proteins but not GAPDH provides an accurate quantification of gene expressions in neuronal differentiation of PC12 cells

Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction.

Identification of Valid Reference Genes for the Normalization of RT-qPCR Expression Studies in Human Breast Cancer Cell Lines Treated with and without Transient Transfection

Comparison of Reference Gene Expression Stability in Mouse Skeletal Muscle Via Five Algorithms.

Suitable Reference Genes for Real-Time PCR in Human HBV-related Hepatocellular Carcinoma with Different Clinical Prognoses

Screening and validation of the optimal panel of reference genes in colonic epithelium and relative cancer cell lines

Identification of stable reference genes for quantitative real-time PCR in human fibroblasts from lymph nodes and synovium

Validation of Reference Genes for Gene Expression Normalization in RAW264.7 Cells under Different Conditions

Identification of suitable reference genes for gene expression studies using quantitative polymerase chain reaction in lung cancer in vitro.

Reference gene evaluation for normalization of gene expression studies with lymph tissue and node‑derived stromal cells of patients with oral squamous cell carcinoma

Reference genes to normalize body fluid identification data obtained using RT-qPCR

Selection of reference genes in liproxstatin-1-treated K562 Leukemia cells via RT-qPCR and RNA sequencing

Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets

Selection of Internal References for Qrt-Pcr Assays of Human Hepatocellular Carcinoma Cell Lines

Identification of Reference Genes for Qrt-Pcr in Human Lung Squamous-Cell Carcinoma by RNA-Seq.

Selection of Reference Genes for Real-Time PCR in Human Hepatocellular Carcinoma Tissues

Abstract 2350: Comparison of normalization methods for RT-qPCR microRNA expression in cancer datasets